Astex Technology - A structure-based drug discovery company pioneering the use of High Throughput X-ray crystallography (HTX) for the rapid identification of novel drug candidates through structural screening-based in Cambridge, UK.


Home		Set as Homepage		Add to Favorite		Contact

21 November, 2008

egories

New Addition

ExecuCare Addiction Recovery Center

Basildon Dentists: Cosmetic Dentistry Basildon, Dental Treatments Basildon

Car leasing

Copthorne Hotel Reading

Security guards

Branded Laptops Suppliers

Best Yeast Infection Cure

Manufacturers Of Ladies Apparel

Cosmetic Products Exporters

Locus Global

Category: Main » Business » Biotechnology and Pharmaceuticals » Pharmaceuticals » Research and Development	UPDATE URL \| REPORT BROKEN LINK
Astex Technology	Popularity: Hit: 13 \| Visit: 0

Details:

	A structure-based drug discovery company pioneering the use of High Throughput X-ray crystallography (HTX) for the rapid identification of novel drug candidates through structural screening-based in Cambridge, UK.
URL:
Title:
Description:	Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Research and Development - Astex Technology. A structure-based drug discovery company pioneering the use of High Throughput X-ray crystallography (HTX) for the rapid identification of novel drug candidates through structural screening-based in Cambridge, UK.
Specialized in:

AlteonPharma (Popularity:

): Development of pharmaceutical products for the complications of diabetes and age-related diseases.
Chiroscience (Popularity:

): Chiroscience Group plc is an emerging pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines ...
MDL Information Systems, Inc. (Popularity:

): MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and ...
Key Oncologics (Pty) Ltd, South Africa (Popularity:

): Biopharmaceutical company with a focus on marketing anticancer pharmaceuticals, and conducting oncology clinical trials.
Pharmadigm, Inc. (Popularity:

): Pharmadigm is developing a new class of anti-inflammatory agent useful in the management of acute inflammatory responses associated with burns, ...
Tuberculosis Research Centre (Popularity:

): Established in 1956 under the auspices of the Indian Council of Medical Research, the World Health Organisation and the British ...
SERAF Therapeutics, Inc. (Popularity:

): Early stage pharmaceutical company specializing in targeted delivery of therapeutic componds to specific immune cells as cost-effective therapy for inflammatory ...
Karo Bio AB (Popularity:

): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
Mercodia (Popularity:

): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Pherin Pharmaceutical (Popularity:

): Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment ...

Popular Sites

AlteonPharma (Popularity:

): Development of pharmaceutical products for the complications of diabetes and age-related diseases.
Mercodia (Popularity:

): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Chiroscience (Popularity:

): Chiroscience Group plc is an emerging pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines ...
ProCertus BioPharm, Inc. (Popularity:

): Developing products that: 1) Protect humans against the debilitating side effects of cancer chemotherapy and radiotherapy, and 2) Protect animals ...
Karo Bio AB (Popularity:

): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.

Related Press

Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway (Popularity:

): Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Aurigene Discovery ...
Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals (Popularity:

): Nuevolution A/S today announced a strategic alliance with Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) aimed at the discovery of novel small ...
GlaxoSmithKline and Cellzome Announce Major Strategic Alliance (Popularity:

): Cellzome Inc. and GlaxoSmithKline (LSE & NYSE: GSK) announce the signing of a worldwide strategic alliance to discover, develop and ...
Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules (Popularity:

): Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced today that the ...
Ingenuity Systems Announces Molecular Toxicology Solution (Popularity:

): Ingenuity Systems, the leading provider of information solutions for the exploration, interpretation, and analysis of experimental data for life sciences ...

Related Articles

The Rising Frequency of Drug Tests (Popularity:

): It was practically unheard of for anyone my age to be using drugs when I was in high school about ...
Drug and Alcohol Rehab (Popularity:

): Rehabilitation from drug addiction is a complex process. It involves commitment from the individual addict to abstain from further drug ...
Drug & Alcohol Addiction Treatment (Popularity:

): Selecting the right drug rehabilitation center is undoubtedly one of the most difficult and challenging decisions a person has to ...
Pre-employment Screening Services And Their Advantage To Employers (Popularity:

): Pre-employment screening services can provide a service to employers that they would find difficult to provide for themselves. There are ...
Are You Looking For Drug Rehab Program? (Popularity:

): If you are looking for drug rehab program then keep on reading this article.A person should have enough information before ...